Boston Scientific Corp

VANGUARD GROUP INC BSX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

139,685,997

Value ($000)

13,319,060

Weight

0.2%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	13,319,060	0.2%	139,685,997	12/31/2025
2025 Q3	11/7/2025	13,497,294	0.2%	138,249,447	9/30/2025
2025 Q2	8/11/2025	14,729,575	0.2%	137,134,110	6/30/2025
2025 Q1	5/9/2025	13,577,311	0.2%	134,588,729	3/31/2025
2024 Q4	2/11/2025	11,869,805	0.2%	132,890,784	12/31/2024
2024 Q3	11/13/2024	11,002,163	0.2%	131,290,722	9/30/2024
2024 Q2	8/13/2024	10,001,325	0.2%	129,870,473	6/30/2024
2024 Q1	5/10/2024	8,728,221	0.2%	127,437,884	3/31/2024
2023 Q4	3/11/2024	7,252,253	0.2%	125,449,802	12/31/2023
2023 Q3	12/18/2023	6,534,969	0.2%	123,768,348	9/30/2023
2023 Q2	8/14/2023	6,612,119	0.2%	122,242,916	6/30/2023
2023 Q1	7/14/2023	6,015,795	0.2%	120,243,746	3/31/2023
2022 Q4	2/10/2023	5,495,663	0.1%	118,773,794	12/31/2022
2022 Q3	11/14/2022	4,527,004	0.1%	116,886,236	9/30/2022
2022 Q2	8/12/2022	4,292,675	0.1%	115,177,740	6/30/2022
2022 Q1	5/13/2022	5,020,927	0.1%	113,364,827	3/31/2022
2021 Q4	2/14/2022	4,741,687	0.1%	111,621,630	12/31/2021
2021 Q3	11/12/2021	4,825,525	0.1%	111,212,803	9/30/2021
2021 Q2	8/13/2021	4,709,377	0.1%	110,135,093	6/30/2021
2021 Q1	5/14/2021	4,244,918	0.1%	109,829,688	3/31/2021
2020 Q4	2/12/2021	3,982,583	0.1%	110,781,158	12/31/2020
2020 Q3	11/16/2020	4,279,748	0.1%	112,005,986	9/30/2020
2020 Q2	8/14/2020	3,971,645	0.1%	113,120,042	6/30/2020
2020 Q1	5/15/2020	3,645,644	0.2%	111,726,752	3/31/2020
2019 Q4	2/14/2020	4,929,743	0.2%	109,016,849	12/31/2019
2014 Q2	8/11/2014	1,218,371	0.1%	95,408,904	6/30/2014
2014 Q1	5/13/2014	1,246,898	0.1%	92,226,186	3/31/2014
2013 Q4	2/12/2014	1,077,694	0.1%	89,658,408	12/31/2013